Abstract:Objective: To assess the effi cacy and safety of intravenous recombinant tissue plasminogen activator (IV-tPA) therapy and combining IV-tPA with neuroendovascular therapy (combined therapy [ComT]) in acute ischemic stroke. Methods: Among 481 consecutive patients with acute ischemic stroke, we investigated the recanalization rate, clinical outcomes three months after stroke onset, and the incidence of symptomatic intracranial hemorrhage (sICH) in 33 patients who received IV-tPA therapy (0.6 mg/kg for 60 minutes… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.